Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open label, pilot phase II study of Glivec in children and adolescents with life threatening diseases known to be associated with one or more Glivec-sensitive tyrosine kinases

Trial Profile

Open label, pilot phase II study of Glivec in children and adolescents with life threatening diseases known to be associated with one or more Glivec-sensitive tyrosine kinases

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2013

At a glance

  • Drugs Imatinib (Primary)
  • Indications Cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top